Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fausto R. Loberiza
Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) Achieving Remission With Blinatumomab
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pcn146 - Inotuzumab Ozogamicin in Patients With Relapsed or Refractory (R/R) Acute Lymphocytic Leukemia (All): Establishing a Value-Based Cost – Preliminary Results
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia
Advances in Therapy
Medicine
Pharmacology
Safety and Efficacy of Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood
Bone Marrow Transplantation
Transplantation
Hematology
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Efficacy and Safety Analysis by Age Cohort of Inotuzumab Ozogamicin in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Enrolled in INO-VATE
Cancer
Cancer Research
Oncology
